Trial intelligence / Profile preview

CBT as Adjunctive Therapy in Schizophrenia Patients on Risperidone

NCT07609953Completed

Sponsor
Hasanuddin University
Start
Nov 2025
Primary completion
Jan 2026
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Hasanuddin University. Primary endpoint: Cognitive Assessment Interview Total Score at 10 weeks. Started Nov 2025; status: completed.

Beyond the preview

Go deeper on NCT07609953.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07609953.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call